Jason Davis insider trades

Open-market stock purchases and sales by Jason Davis, Chief Financial Officer at FibroBiologics, Inc, from SEC Form 4 filings since Jan 8, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +149%.

Recent trades

DateStockTradeValue
May 4, 2026FBLG FibroBiologics, IncBought (not open market)—
Mar 2, 2026FBLG FibroBiologics, IncBought$29K

Companies traded

  • FBLG FibroBiologics, Inc: 1 buy, last May 4, 2026
  • HDYN Hyperdynamics Corp: 1 buy, last Jul 17, 2017
  • HDY Hyperdynamics Corp: other filings, last Jun 30, 2014

Get free alerts when Jason Davis files a new trade →